Literature DB >> 28410712

Swept-source optical coherence tomography to screen for macular pathology in eyes having routine cataract surgery.

Sidra Zafar1, M A Rehman Siddiqui2, Rida Shahzad1, Masroor H Shahzad1.   

Abstract

PURPOSE: To determine the incremental benefit of swept-source optical coherence tomography (SS-OCT) in identifying occult macular disease preoperatively in patients scheduled for routine cataract surgery.
SETTING: Shahzad Eye Hospital, Karachi, Pakistan.
DESIGN: Prospective case series.
METHODS: Preoperative SS-OCT scans were performed in all patients scheduled to have cataract surgery between January and March 2016. Scans were subsequently reviewed for the presence of macular abnormalities. Patients with clinically detectable retinal pathologies were excluded.
RESULTS: Of the 179 eligible patients, 155 were included in the study. Macular pathology was noted in 17 patients (10.9%). The most commonly identified conditions were age-related macular degeneration (n = 5), idiopathic epiretinal membrane (n = 4), and vitreomacular interface abnormalities (n = 4). Other abnormalities included cystoid macular edema (n = 2) and ellipsoid zone abnormalities (n = 2). Media opacities precluded interpretation of 9 scans (4.7%).
CONCLUSIONS: Swept-source OCT was an effective noninvasive modality for detecting macular structural abnormalities, especially in the presence media opacities. Optical coherence tomography imaging should be considered as an adjunct to routine dilated fundus examination for macular evaluation, particularly if premium intraocular lenses are being considered.
Copyright © 2017 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28410712     DOI: 10.1016/j.jcrs.2016.12.022

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  8 in total

1.  Cost-Effectiveness of Preoperative OCT in Cataract Evaluation for Multifocal Intraocular Lens.

Authors:  Ella H Leung; Allister Gibbons; Douglas D Koch
Journal:  Ophthalmology       Date:  2020-01-31       Impact factor: 12.079

2.  Macular assessment of preoperative optical coherence tomography in ageing Chinese undergoing routine cataract surgery.

Authors:  Xiaoli Huang; Zhengwei Zhang; Jie Wang; Xiaomei Meng; Tiantian Chen; Zhifeng Wu
Journal:  Sci Rep       Date:  2018-03-23       Impact factor: 4.379

3.  Optical coherence tomography findings in patients prior to cataract surgery regarded as unremarkable with ophthalmoscopy.

Authors:  Antonia Kowallick; Charlotte Viola Fischer; Hans Hoerauf
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

4.  Swept-Source Optical Coherence Tomography Biometer as Screening Strategy for Macular Disease in Patients Scheduled for Cataract Surgery.

Authors:  Daniele Tognetto; Marco R Pastore; Chiara De Giacinto; Riccardo Merli; Marco Franzon; Rossella D'Aloisio; Lorenzo Belfanti; Rosa Giglio; Gabriella Cirigliano
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

5.  Prevalence of Macular Abnormalities Identified Only on Optical Coherence Tomography in Korean Patients Scheduled for Cataract Surgery.

Authors:  Seo-Yeon Hong; Seonjoo Kim; So-Hyang Chung
Journal:  Korean J Ophthalmol       Date:  2021-02-18

6.  Macular Optical Coherence Tomography before Cataract Surgery.

Authors:  Yousef Alizadeh; Mitra Akbari; Reza Soltani Moghadam; Abdolreza Medghalchi; Maryam Dourandeesh; Fariborz Bromandpoor
Journal:  J Curr Ophthalmol       Date:  2021-10-22

7.  Impact of lens opacity and axial length on concomitant screening of maculopathy by swept-source optical coherence tomography-based optical biometer.

Authors:  Yingyan Qin; Shaobi Ye; Liangping Liu; Mingxing Wu
Journal:  Ann Transl Med       Date:  2022-08

8.  Preoperative fundoscopy versus optical coherence tomography to detect occult maculopathy during cataract surgery preassessment.

Authors:  George Murphy; Raisah Owasil; Sam Kanavati; Zahra Ashena; Mayank A Nanavaty
Journal:  Eye (Lond)       Date:  2022-03-24       Impact factor: 4.456

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.